- Home
- ECOR vs DPRO Comparison
ECOR vs DPRO Comparison
Compare ECOR & DPRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ECOR
- DPRO
- Stock Information
- Founded
- ECOR 2005
- DPRO 1998
- Country
- ECOR United States
- DPRO Canada
- Employees
- ECOR N/A
- DPRO N/A
- Industry
- ECOR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- DPRO Aerospace
- Sector
- ECOR Health Care
- DPRO Industrials
- Exchange
- ECOR Nasdaq
- DPRO Nasdaq
- Market Cap
- ECOR 39.7M
- DPRO 38.9M
- IPO Year
- ECOR 2018
- DPRO N/A
- Fundamental
- Price
- ECOR $7.75
- DPRO $5.90
- Analyst Decision
- ECOR Strong Buy
- DPRO Strong Buy
- Analyst Count
- ECOR 2
- DPRO 2
- Target Price
- ECOR $25.50
- DPRO $6.50
- AVG Volume (30 Days)
- ECOR 118.8K
- DPRO 6.8M
- Earning Date
- ECOR 08-06-2025
- DPRO 08-12-2025
- Dividend Yield
- ECOR N/A
- DPRO N/A
- EPS Growth
- ECOR N/A
- DPRO N/A
- EPS
- ECOR N/A
- DPRO N/A
- Revenue
- ECOR $26,458,000.00
- DPRO $4,716,450.00
- Revenue This Year
- ECOR $23.21
- DPRO $94.01
- Revenue Next Year
- ECOR $44.10
- DPRO $95.14
- P/E Ratio
- ECOR N/A
- DPRO N/A
- Revenue Growth
- ECOR 41.54
- DPRO 7.90
- 52 Week Low
- ECOR $4.47
- DPRO $1.55
- 52 Week High
- ECOR $19.49
- DPRO $7.31
- Technical
- Relative Strength Index (RSI)
- ECOR 64.43
- DPRO 63.03
- Support Level
- ECOR $6.57
- DPRO $5.70
- Resistance Level
- ECOR $7.80
- DPRO $6.60
- Average True Range (ATR)
- ECOR 0.74
- DPRO 0.76
- MACD
- ECOR 0.03
- DPRO 0.15
- Stochastic Oscillator
- ECOR 63.97
- DPRO 65.52
About ECOR electroCore Inc.
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.
About DPRO Draganfly Inc.
Draganfly Inc is a Canada based company. It is engaged in the provision of engineering services and the manufacture of commercial unmanned vehicle systems and software. The company operates in Canada, the United States, and Internationally. The three segments are Drones, Vital (Vital Intelligence), and Corporate. The Drones segment derives its revenue from products and services related to the sale of unmanned aerial vehicles (UAV). The Vital segment derives its revenue from the sale of products that measure vitals to help detect symptoms from large groups of people from a distance. The Corporate segment includes all costs not directly associated with the Drone and Vital segments. It generates majority of its revenue from Drones segment.